Brevan Howard Capital Management LP Cuts Stock Holdings in DaVita Inc. (NYSE:DVA)

Brevan Howard Capital Management LP lessened its position in DaVita Inc. (NYSE:DVA - Free Report) by 32.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 8,672 shares of the company's stock after selling 4,101 shares during the quarter. Brevan Howard Capital Management LP's holdings in DaVita were worth $1,297,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the company. SBI Securities Co. Ltd. purchased a new position in DaVita in the 4th quarter valued at $41,000. Coppell Advisory Solutions LLC raised its position in shares of DaVita by 50.0% in the fourth quarter. Coppell Advisory Solutions LLC now owns 300 shares of the company's stock valued at $45,000 after buying an additional 100 shares during the last quarter. Canada Post Corp Registered Pension Plan purchased a new position in shares of DaVita in the fourth quarter worth about $55,000. Venturi Wealth Management LLC boosted its position in DaVita by 59.8% during the fourth quarter. Venturi Wealth Management LLC now owns 406 shares of the company's stock worth $61,000 after acquiring an additional 152 shares during the last quarter. Finally, Blue Trust Inc. grew its stake in DaVita by 39.7% during the 4th quarter. Blue Trust Inc. now owns 461 shares of the company's stock valued at $76,000 after acquiring an additional 131 shares in the last quarter. 90.12% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on DVA shares. StockNews.com upgraded DaVita from a "hold" rating to a "buy" rating in a report on Friday, April 25th. Sanford C. Bernstein set a $184.00 price objective on DaVita in a research note on Friday, February 21st. Cowen reaffirmed a "hold" rating on shares of DaVita in a research note on Tuesday, February 18th. Finally, Barclays boosted their price target on shares of DaVita from $164.00 to $169.00 and gave the company an "equal weight" rating in a research report on Tuesday, February 18th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and two have given a buy rating to the stock. According to MarketBeat, DaVita presently has a consensus rating of "Hold" and a consensus price target of $166.33.

DaVita Price Performance

DVA stock opened at $143.91 on Thursday. DaVita Inc. has a 52-week low of $131.44 and a 52-week high of $179.60. The business has a fifty day moving average of $145.80 and a two-hundred day moving average of $154.20. The stock has a market cap of $11.06 billion, a price-to-earnings ratio of 13.40, a price-to-earnings-growth ratio of 1.07 and a beta of 1.14. The company has a quick ratio of 1.21, a current ratio of 1.26 and a debt-to-equity ratio of 23.18.

DaVita (NYSE:DVA - Get Free Report) last posted its earnings results on Thursday, February 13th. The company reported $2.24 EPS for the quarter, beating analysts' consensus estimates of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. As a group, research analysts anticipate that DaVita Inc. will post 10.76 earnings per share for the current year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.